Showing results (321-330 of 475) with videos related to

Sort By:
Pageof 48
Life Sciences|January 1, 1993
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonistsR B Rothman, K M Becketts, L R Radesca, et al.
British Journal of Pharmacology|February 28, 2002
Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptorsM C H Ko, N N Naughton, J R Traynor, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2007
Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in ratsY Zhao, G R Valdez, E M Fekete, et al.
Synapse (New York, N.Y.)|January 1, 1987
PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agentC A Tamminga, K Tanimoto, S Kuo, et al.
Neuroscience|October 17, 2009
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1betaS S Lewis, M R Hutchinson, N Rezvani, et al.
Neuroscience Letters|January 22, 1990
MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by COT Nabeshima, S Yoshida, H Morinaka, et al.
Synapse (New York, N.Y.)|September 29, 1999
Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assayD V Romero, J S Partilla, Q X Zheng, et al.
Psychopharmacology|September 1, 1996
Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaineJ K Staley, Q Ouyang, J Pablo, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systemsI Fedorova, A Hashimoto, R A Fecik, et al.
Neuropharmacology|August 1, 1991
In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine [correction of fluorothienylcycloexylpiperidine], a possible ligand for positron emission tomographyC Ferrarese, A Guidotti, E Costa, et al.
Pageof 48